8035.T (8035.T)

$17.74T
Market Cap
33.0
P/E Ratio
1.29
Beta
1.53%
Dividend Yield
Piotroski 7/9Altman Z 17.1 Safe

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 7/9, Altman Z 17.1 (above 3.0 safe zone threshold).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics of this entity demonstrate a robust quality profile characterized by an ROIC exceeding 28%, indicating highly efficient capital deployment relative to the cost of equity. This superior return is primarily driven by exceptional profitability metrics rather than operational leverage or asset intensity, as evidenced by a net margin of 22.4% and a gross margin of 47.1%. The DuPont decomposition suggests that high margins are the dominant engine for returns, supported by strong revenue growth of 32.8% YoY which fuels top-line expansion without diluting profit quality. Creditworthiness is further affirmed by an Altman Z-Score of 17.1 and a Piotroski F-Score of 7/9, signaling low bankruptcy risk and sustained financial strength compared to historical norms.

Valuation multiples currently sit at 33.0x P/E, which requires contextualization against sector averages and the company's own historical range to determine if the premium is justified by its growth trajectory or speculative sentiment. A DCF analysis implies a fair value of $31,914; comparing this intrinsic estimate directly against current market pricing reveals whether the stock trades at a discount or premium relative to calculated cash flow potential. The market appears to be pricing in significant future earnings expansion given the wide gap between typical valuation multiples and the 32.8% revenue growth rate, though investors must assess if these high-growth expectations are fully embedded in current share prices before concluding on margin of safety.

Risk assessment relies heavily on monitoring whether such aggressive growth rates can sustain over time without compressing margins or eroding the high ROIC foundation currently observed. While the Piotroski score indicates stable fundamentals, any deviation from the 32.8% revenue expansion could rapidly alter valuation dynamics and pressure the multiple toward historical means. The combination of a low bankruptcy risk profile and strong profitability creates a compelling case for capital appreciation if growth persists, yet the elevated P/E leaves little room for error should execution falter or macroeconomic conditions tighten credit spreads affecting high-growth sectors.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →8%10%12%
2%$38840$28646$22569
3%$45406$31914$24462
4%$55254$36272$26827

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=10.0%, terminal growth 3%. Fair value $31914 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

7/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
17.1
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.

Profitability & Value Creation

47.1%
Gross Margin
22.4%
Net Margin
28.3%
ROIC
+32.8%
Revenue Growth (YoY)
+49.5%
Earnings Growth (YoY)
414.1B
Free Cash Flow
57%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

Balance Sheet Health

0.42x
Debt / Equity
2.66x
Current Ratio
2.39%
FCF Yield
759.6B
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $283.43
Act: $311.99
+10.1%
Q3
✗ Miss
Est: $270.99
Act: $257.13
-5.1%
Q2
✗ Miss
Est: $270.71
Act: $270.18
-0.2%
Q1
✗ Miss
Est: $270.60
Act: $258.59
-4.4%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

30.3
Forward P/E
PEG Ratio
8.88
Price/Book
3M
Avg Volume
$46600.00
52W High
$16560.00
52W Low
52W Range Position

ETF Contagion Visualizer

Simulate a price drop in 8035.T to visualize passive redemption contagion across ETFs and collateral stocks.

8035.T Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
8035.TEpicenterEWJETF8306.THigh Risk7203.TMed Risk6501.TLow Risk6857.TLow Risk8316.THigh Risk
8035.T Price Drop (%)0

If 8035.T (8035.T) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Mitsubishi UFJ Financial Group Inc (8306.T) as the most exposed collateral stock, sharing 1 ETFs with 8035.T. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 1 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

8035.T Ownership Dynamics

Ticker
8035.T

ETFs with Highest 8035.T Exposure

Float lock-up computed from 0 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

8035.T Capital Efficiency

How efficiently does 8035.T convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$414.1B
EBITDA
$759.6B
FCF Conversion
55%
Reinvestment Rate
45%
55% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)

8035.T converts 55% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Compare 8035.T to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.